Discontinued Operations - Summary of Significant Noncash Items and Cash Paid for Capital Expenditures of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	$ 35,731	$ 46,950	$ 28,102
Goodwill impairment of discontinued operations	146,757	0	0
Amortization of debt issuance costs	15,692	4,789	4,845
Discontinued Operations, Disposed of by Sale | Life Sciences
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Depreciation and amortization	35,731	46,950	28,102
Goodwill impairment of discontinued operations	146,757	0	0
Amortization of debt issuance costs	13,990	3,368	3,571
Loss on extinguishment of debt and write-off of debt issuance costs	1,388	2,753	19,562
Acquisition of property, plant and equipment	8,416	21,834	14,759
Right-of-use assets obtained in exchange for new finance lease liabilities	695	5,321	0
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 6,174	$ 51	$ 0